Phase II study of individualized adaptive stereotactic body radiotherapy (SBRT) for patients at high risk for liver damage.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2467113945
